Alkermes, Inc. is a biopharmaceutical company that develops and manufactures medicines. Its filings show it lobbies Congress mainly on pharmacy-related regulatory and legislative issues and on federal funding (appropriations) that affect the company. It hires Penn Avenue Partners to represent its interests.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
CHRISTINA MCGARRY DAVID
The latest disclosures for this client.
PENN AVENUE PARTNERS
Q1PENN AVENUE PARTNERS
Q4The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
PENN AVENUE PARTNERS
JAY SULZMANN
PENN AVENUE PARTNERS
JERR ROSENBAUM
PENN AVENUE PARTNERS
mr TIMOTHY FARRELL HANNEGAN
PENN AVENUE PARTNERS
PENN AVENUE PARTNERS
Q3PENN AVENUE PARTNERS
Q2PENN AVENUE PARTNERS
Q1